MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, following encouraging results from the company’s phase 2b trial of its lead ...
MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...
Artemis 2 will be the first mission to carry humans to the moon's vicinity since 1972. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Artemis 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback